|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Alpa Laboratories Ltd.
Main Activities: Chemical Manufacturing - Health and Personal Care Stores
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Alpa Laboratories Ltd. Legal Address 33/2, Pigdamber,, A B Road, Rau; Indore; Madhya Pradesh; 453446 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational ISIN CODE : INE385I01010 Financial Auditors: C H Padliya & Co. (2012) Incorporation Date: March 18, 1988 Tel: 4294567 |
|
Company Description |
| Alpa Laboratories has been manufacturing Pharmaceutical Finished Dosage Forms since 1967. With its focus on quality, the company has earned tremendous faith and confidence of its associates. Alpa Laboratories manufactures a wide range of products under its own brand and for a number of other reputed Indian and multinational companies. The product range includes a wide variety of ethical, generic and over the counter (OTC) drugs in various Finished Dosage Forms for both human and veterinary use. | ||
|
||
Company Analysis |
| According to the Individual - Audited financial statement for the Year of 2012, total net operating revenues decreased with -33.36%, from INR 83.58 tens of millions to INR 55.7 tens of millions. Operating result increased from INR 2.15 tens of millions to INR 2.56 tens of millions which means 19.07% change. The results of the period decreased -66.03% reaching INR 0.53 tens of millions at the end of the period against INR 1.56 tens of millions last year. Return on equity (Net income/Total equity) went from 1.60% to 0.54%, the Return On Asset (Net income / Total Asset) went from 1.61% to 0.56% and the Net Profit Margin (Net Income/Net Sales) went from 1.87% to 0.95% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 10.97% compared to 9.90% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 2.10 to 2.03 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2013 Q3C (non-cons) |
2013 H1 (non-cons) |
|
 | ||
| Non-Audited | Non-Audited | |
| ||
| Dion Global Solutions - AsianCERC | Dion Global Solutions - AsianCERC | |
| ||
| Unit | Tens of Millions) | Tens of Millions |
| ||
Balance Sheet
| ||
Shareholders Equity |
21 |
21 |
| ||
| * All the accounts are in INR. | ||
Income Statement
| ||
Total Operating Revenue |
37 |
25 |
| ||
Operational Profit (Loss) |
-0 |
0 |
| ||
Net Profit (Loss) |
-1 |
0 |
| ||
| * All the accounts are in INR. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Equity (ROE) |
-8.41% |
0.29% |
| ||
Annualised Return on Equity (ROE) |
-11.21% |
0.58% |
| ||
Return on Sales (ROS) |
101.95% |
101.5% |
| ||
 |